AI assistant
Sending…
Entrada Therapeutics, Inc. — Director's Dealing 2021
Oct 29, 2021
33674_dirs_2021-10-28_e86453d2-6bab-4d30-bee8-4c4b96f5d86b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Entrada Therapeutics, Inc. (TRDA)
CIK: 0001689375
Period of Report: 2021-10-28
Reporting Person: Nuechterlein Carole (Director)
More from Entrada Therapeutics, Inc.
Report Publication Announcement
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26